Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size

  • Report ID: 3596
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Outlook:

Necrotizing Ulcerative Gingivitis (NUG) Treatment Market size was over USD 1.36 billion in 2025 and is anticipated to cross USD 4.26 billion by 2035, growing at more than 12.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of necrotizing ulcerative gingivitis treatment is estimated at USD 1.51 billion.

The growth of the market can be attributed to the rising number of people suffering from HIV or AIDs across the world. The presence of HIV or AIDs increases the risk of oral issues as HIV suppresses the immune system of the body making it weak to fight against any smaller disease or infection. HIV-associated gingivitis is called linear gingival erythema and is caused by herpes simplex virus type 1 (HSV-1). As per the statistical report of the World Health Organization, 38.4 million population around the globe was suffering from HIV by the end of 2021, and about 650,000 people died from HIV and other related illnesses in the same year.

Also, the poor oral habits of people across the world especially in rural areas owing to lack of knowledge is estimated to propel the market growth in the coming years. Oral hygiene is most important to avoid or prevent any kind of teeth, gum, and oral infections and diseases. The increasing number of people suffering from the formation of plaque around the teeth as well as swollen gums is estimated to drive the market growth during the forecast period. Regular brushing and flossing of teeth are very important for oral health and remove the presence of bacteria or fungi deposits. As per the reports of 2019, more than 30% of the American population failed to brush their teeth two times a day, and over 1.6 % of people admitted that they do not brush at least once a day.


Necrotizing Ulcerative Gingivitis (NUG) Treatment Market

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of necrotizing ulcerative gingivitis treatment is estimated at USD 1.51 billion.

The global necrotizing ulcerative gingivitis treatment market size was more than USD 1.36 billion in 2025 and is anticipated to grow at a CAGR of over 12.1%, reaching USD 4.26 billion revenue by 2035.

By 2035, North America is projected to secure a 32% share in the Necrotizing Ulcerative Gingivitis (NUG) Treatment Market, supported by rising oral disease prevalence, poor dietary habits, and increasing cases of diabetes.

Key players in the market include Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos